Agata Chmurzynska

Dr. Agata Chmurzynska

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2006 in Journal of Applied Genetics
Verified
Journal Article
Closed access
PDF file
ACAgata Chmurzynska
Agata Chmurzynska

1 February 2010 in Nutrition Reviews
Verified
Journal Article
Closed access
ACAgata Chmurzynska
Agata Chmurzynska

8 July 2017 in Lifestyle Genomics
Verified
Journal Article
Open access
PDF file
OROmar Ramos-Lopez
Omar Ramos-Lopez
Fermín I. MilagroFermín I. Milagro
Fermín I. Milagro
HAHooman Allayee
Hooman Allayee
ACAgata Chmurzynska
Agata Chmurzynska
MCMyung Sook Choi
Myung Sook Choi
JMJ. Alfredo Martinez
J. Alfredo Martinez
Chronic diseases, including obesity, are major causes of morbidity and mortality in most countries. The adverse impacts of obesity and associated comorbidities on health remain a major concern due to the lack of effective interventions for prevention and management. Precision nutrition is an emerging therapeutic approach that takes into account an individual's genetic and epigenetic information, as well as age, gender, or particular physiopathological status. Advances in genomic sciences are contributing to a better understanding of the role of genetic variants and epigenetic signatures as well as gene expression patterns in the development of diverse chronic conditions, and how they may modify therapeutic responses. This knowledge has led to the search for genetic and epigenetic biomarkers to predict the risk of developing chronic diseases and personalizing their prevention and treatment. Additionally, original nutritional interventions based on nutrients and bioactive dietary compounds that can modify epigenetic marks and gene expression have been implemented. Although caution must be exercised, these scientific insights are paving the way for the design of innovative strategies for the control of chronic diseases accompanying obesity. This document provides a number of examples of the huge potential of understanding nutrigenetic, nutrigenomic, and nutriepigenetic roles in precision nutrition.

24 July 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Joanna BajerskaJoanna Bajerska
Joanna Bajerska
ACAgata Chmurzynska
Agata Chmurzynska
AMAgata Muzsik
Agata Muzsik
PKPatrycja Krzyżanowska-Jankowska
Patrycja Krzyżanowska-Jankowska
EMEdyta Mądry
Edyta Mądry
JWJarosław Walkowiak
Jarosław Walkowiak
We conducted a randomized controlled trial to examine the effect of two energy-restricted diets on body weight (BW), visceral fat (VF) loss, and the risk factors for metabolic syndrome. A total of 144 centrally obese postmenopausal women were assigned to the moderate in fat Mediterranean diet (MED) or to the Central European diet (CED), which is moderate in carbohydrates and high in dietary fiber (DF), for 16 weeks. BW, waist circumference and VF were significantly reduced by 8.8%, 7.0%, and 24.6%, respectively, over the trial (P < 0.001), with no difference between groups. A similar trend was seen for total cholesterol, triglycerides, glucose, and blood pressure. Within each diet group, the more adherent participants lost significantly more BW than did their less adherent counterparts. VF was significantly reduced only in women who were more adherent to the CED, and the reduction in VF correlated with an increase in the proportion of DF. Short-term dietary treatment with the CED or the MED was associated with similar improvements in some anthropometric, lipid, and nonlipid parameters; however, adequate adherence to the prescribed diet is important in weight loss success and in achieving improvements in metabolic health.

4 June 2020 in Nutrition Journal
Verified
Journal Article
Open access
PDF file
MMMonika A. Mlodzik-Czyzewska
Monika A. Mlodzik-Czyzewska
AMAnna M. Malinowska
Anna M. Malinowska
ACAgata Chmurzynska
Agata Chmurzynska
Background: The link between folate metabolism and obesity has recently been underlined, suggesting that folate deficiency may lead to body weight gain and adiposity. We thus wished to determine whether the inefficiency in folate metabolism caused by genetic variation in the MTHFR and DHFR genes in folate metabolism, or inadequate folate intake, is associated with obesity. Methods: A case–control study including 421 healthy participants (aged 20–40) was performed in Poznań, Poland. The cases were 213 subjects with BMI > 25 kg/m2, while the controls were 208 subjects with BMI < 25 kg/m2. Genotyping of rs70991108 (DHFR) and rs1801133 (MTHFR) was performed using TaqMan probes. Serum folate concentrations were measured using an enzyme-linked immunosorbent assay and homocysteine was assessed with high performance liquid chromatography. Results: Subjects with overweight and obesity had 12% lower folate intake (p < 0.05) and 8.5% lower folate serum concentrations (p < 0.01) than the controls. Serum folate concentrations and folate intake were inversely associated with body fat percentage (p < 0.05) and waist circumference (p < 0.05 and p < 0.001, respectively). Serum folate concentration, though not folate intake, was negatively associated with WHR and BMI (p < 0.05, for both associations). Conclusions: Lower folate intake and serum levels are weakly, but independently, associated with greater body weight and central adiposity in people aged 20–40. MTHFR and DHFR polymorphism seems not to have significant impact on body weight.

1 March 2019 in Biochimie
Verified
Journal Article
Closed access
ARAnna Radziejewska
Anna Radziejewska
ACAgata Chmurzynska
Agata Chmurzynska